YiChang HEC Pharm Raises $400 Million from Blackstone Group

YiChang HEC ChangJiang Pharm raised $400 million from Blackstone Group in the a convertible bond offering. The bonds will pay 3%. HEC Pharm, based in Yichang in central China ’s Hubei province, will use the funds to acquire additional drugs and other pharmaceutical products. Blackstone will help HEC Pharm in its M&A pursuit and also advise the company on improving strategy, operations and international cooperation. More details.... Stock Symbols: (HK: 1558) (NYSE: BX) Share this with colleagues: // //